{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:40:52Z","timestamp":1768315252563,"version":"3.49.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T00:00:00Z","timestamp":1395705600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0092606","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T20:52:07Z","timestamp":1395780727000},"page":"e92606","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["The VACS Index Accurately Predicts Mortality and Treatment Response among Multi-Drug Resistant HIV Infected Patients Participating in the Options in Management with Antiretrovirals (OPTIMA) Study"],"prefix":"10.1371","volume":"9","author":[{"given":"Sheldon T.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet P.","family":"Tate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tassos C.","family":"Kyriakides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine A.","family":"Kirkwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Holodniy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph L.","family":"Goulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Angus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. William","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy C.","family":"Justice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the OPTIMA Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,3,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1097\/QAD.0b013e3283316a5e","article-title":"Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials","volume":"23","author":"C Katlama","year":"2009","journal-title":"AIDS"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1086\/650002","article-title":"Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials","volume":"50","author":"RT Steigbigel","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/QAD.0b013e3283365356","article-title":"Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV","volume":"24","author":"J Neuhaus","year":"2010","journal-title":"AIDS"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"WM El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/QAD.0b013e32833b1b26","article-title":"Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients","volume":"24","author":"AC Achhra","year":"2010","journal-title":"AIDS"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1468-1293.2008.00643.x","article-title":"Antiretroviral effects on HIV-1 RNA, CD4 cell count and progression to AIDS or death: a meta-regression analysis","volume":"9","author":"EJ Mills","year":"2008","journal-title":"HIV Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1097\/QAD.0b013e32834cdb4b","article-title":"Fatal and non-fatal AIDS and non-AIDS events in HIV-1 positive individuals with high CD4 counts according to viral load strata","volume":"25","author":"J Reekie","year":"2011","journal-title":"AIDS"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/QAI.0b013e31827df36c","article-title":"Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis","volume":"62","author":"AC Justice","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cid\/cir989","article-title":"Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?","volume":"54","author":"AC Justice","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/QAD.0b013e32835b8c7f","article-title":"An internationally generalizable risk index for mortality after one year of antiretroviral therapy","volume":"27","author":"JP Tate","year":"2013","journal-title":"AIDS"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/cid\/cis539","article-title":"Reply to Chow et al","volume":"55","author":"AC Justice","year":"2012","journal-title":"Clinical infectious diseases"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e14764","DOI":"10.1371\/journal.pone.0014764","article-title":"Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial","volume":"6","author":"M Holodniy","year":"2011","journal-title":"PLoS ONE"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1468-1293.2009.00757.x","article-title":"Towards a combined prognostic index for survival in HIV infection: the role of \u2018non-HIV\u2019 biomarkers","volume":"11","author":"AC Justice","year":"2010","journal-title":"HIV Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/sim.1825","article-title":"Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy","volume":"23","author":"M May","year":"2004","journal-title":"Stat Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/QAD.0b013e328270b877","article-title":"Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score","volume":"21","author":"A Mocroft","year":"2007","journal-title":"AIDS"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0197-2456(03)00029-1","article-title":"An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA Trial","volume":"24","author":"TC Kyriakides","year":"2003","journal-title":"Control Clin Trials"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"RK Sterling","year":"2006","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function-measured and estimated glomerular filtration rate","volume":"354","author":"LA Stevens","year":"2006","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-150-11-200906020-00007","article-title":"Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures","volume":"150","author":"NR Cook","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","article-title":"Use and misuse of the receiver operating characteristic curve in risk prediction","volume":"115","author":"NR Cook","year":"2007","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-130-6-199903160-00016","article-title":"Assessing the generalizability of prognostic information","volume":"130","author":"AC Justice","year":"1999","journal-title":"Ann Intern Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ahj.2007.02.027","article-title":"Prediction of first coronary events with the Framingham score: A systematic review","volume":"153","author":"K Eichler","year":"2007","journal-title":"American Heart Journal"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/QAI.0b013e31825b70d9","article-title":"Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study","volume":"60","author":"RK Medapalli","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"MS Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1086\/508182","article-title":"A trial of integrated buprenorphine\/naloxone and HIV clinical care","volume":"43","author":"LE Sullivan","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0092606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T10:41:03Z","timestamp":1716633663000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0092606"}},"subtitle":[],"editor":[{"given":"Ivan Cruz","family":"Moura","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,25]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0092606","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,25]]}}}